Kermani-Alghoraishi Mohammad, Shirvani Ehsan, Khosravi Alireza, Roghani-Dehkordi Farshad, Shemirani Hasan, Farshidi Hossein, Assareh Ahmad Reza, Moezi Seyyed Ali, Sarrafzadegan Nizal
Assistant Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Assistant Professor, Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
ARYA Atheroscler. 2021 Mar;17(2):1-7. doi: 10.22122/arya.v17i0.2320.
With the onset of the coronavirus disease-2019 (COVID-19) pandemic, hospitalization and treatment of non-covid patients decreased worldwide. The aim of this study is to evaluate the admission and treatment of patients with coronary artery diseases (CADs) by examining coronary Cath labs activities in some centers of Iran during the COVID-19 period.
A retrospective, multi-center survey was conducted in four cites in Iran which participated in National Persian Registry Of CardioVascular diseasE (N-PROVE). Two periods of COVID-19 occurrence peak in Iran were compared with the same date in 2019. Information was collected on the number of diagnostic and therapeutic coronary catheterizations in both stable ischemic heart diseases (SIHDs) and acute coronary syndrome (ACS) settings.
In the first peak of COVID-19 pandemic, coronary angiographies and angioplasties decreased by 37 and 38% compared to the same period in 2019, respectively. The most common indication for coronary angiography during this period was ACS [especially ST-Segment Elevation Myocardial Infarction (STEMI)]; however, at the time of peak decrease, the SIHDs were the most. In the second peak of COVID-19 pandemic in Iran, 34% and 27% decrease in diagnostic and therapeutic coronary procedures were seen, respectively. During this period, the number of elective admissions increased, although it was still lower than that in 2019. The tendency to rescue percutaneous coronary intervention increased in most centers during the COVID-19 era, especially in the second peak.
A significant reduction in the coronary Cath lab activity has been observed during the COVID-19 pandemic that can indicate an increased risk of cardiovascular mortality and morbidity.
随着2019冠状病毒病（COVID-19）大流行的爆发，全球范围内非COVID患者的住院和治疗有所减少。本研究的目的是通过检查伊朗部分中心在COVID-19期间冠状动脉造影实验室的活动，评估冠状动脉疾病（CAD）患者的入院和治疗情况。
在伊朗参与国家心血管疾病波斯登记处（N-PROVE）的四个城市进行了一项回顾性多中心调查。将伊朗COVID-19发病高峰期的两个时间段与2019年的同一日期进行比较。收集了稳定型缺血性心脏病（SIHD）和急性冠状动脉综合征（ACS）患者诊断性和治疗性冠状动脉导管插入术的数量信息。
在COVID-19大流行的第一个高峰期，冠状动脉造影和血管成形术与2019年同期相比分别下降了37%和38%。在此期间，冠状动脉造影最常见的指征是ACS[尤其是ST段抬高型心肌梗死（STEMI）]；然而，在下降高峰期，SIHD患者最多。在伊朗COVID-19大流行的第二个高峰期，诊断性和治疗性冠状动脉手术分别下降了34%和27%。在此期间，择期入院人数有所增加，尽管仍低于2019年。在COVID-19时代，大多数中心挽救性经皮冠状动脉介入治疗的趋势有所增加，尤其是在第二个高峰期。
在COVID-19大流行期间，观察到冠状动脉造影实验室活动显著减少，这可能表明心血管疾病死亡率和发病率风险增加。
